CRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Misses Revenue Estimates
CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of -8.76% and 93.84%, respectively, for the quarter ended June 2024. Do…
35,820$
-0,89%
Echtzeit-Aktienkurs CRISPR Therapeutics AG
Bid:
Ask:
Nachrichten zur CRISPR Therapeutics AG Aktie
CRISPR Therapeutics AG (CRSP) Jefferies 2024 Global Healthcare Conference (Transcript)
…
CRISPR Therapeutics AG (CRSP) BofA Securities 2024 Health Care Conference (Transcript)
…
CRISPR Therapeutics AG (CRSP) Annual Needham Virtual Healthcare Conference - (Transcript)
…
CRISPR Therapeutics to nominate Christian Rommel to board By Investing.com
CRISPR Therapeutics to nominate Christian Rommel to board…